367 related articles for article (PubMed ID: 33064950)
1. Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry.
Kolaitis NA; Zamanian RT; de Jesus Perez VA; Badesch DB; Benza RL; Burger CD; Chakinala MM; Elwing JM; Feldman J; Lammi MR; Mathai SC; McConnell JW; Presberg KW; Robinson JC; Sager J; Shlobin OA; Simon MA; Kawut SM; Glidden DV; Singer JP; De Marco T;
Ann Am Thorac Soc; 2021 Apr; 18(4):613-622. PubMed ID: 33064950
[No Abstract] [Full Text] [Related]
2. Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension.
Zamanian RT; Hedlin H; Greuenwald P; Wilson DM; Segal JI; Jorden M; Kudelko K; Liu J; Hsi A; Rupp A; Sweatt AJ; Tuder R; Berry GJ; Rabinovitch M; Doyle RL; de Jesus Perez V; Kawut SM
Am J Respir Crit Care Med; 2018 Mar; 197(6):788-800. PubMed ID: 28934596
[TBL] [Abstract][Full Text] [Related]
3. Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.
Chung L; Liu J; Parsons L; Hassoun PM; McGoon M; Badesch DB; Miller DP; Nicolls MR; Zamanian RT
Chest; 2010 Dec; 138(6):1383-94. PubMed ID: 20507945
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Long-Term Oral Bosentan in Different Types of Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.
Kuang HY; Li Q; Du HA; Chen M; Yin YH
Am J Cardiovasc Drugs; 2021 Mar; 21(2):181-191. PubMed ID: 32918210
[TBL] [Abstract][Full Text] [Related]
5. Methamphetamine and the risk of pulmonary arterial hypertension.
Ramirez RL; Perez VJ; Zamanian RT
Curr Opin Pulm Med; 2018 Sep; 24(5):416-424. PubMed ID: 30036313
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR).
Garry JD; Kolaitis NA; Kronmal R; Thenappan T; Hemnes A; Grinnan D; Bull T; Chakinala MM; Horn E; Simon MA; De Marco T;
J Heart Lung Transplant; 2022 Dec; 41(12):1808-1818. PubMed ID: 36150996
[TBL] [Abstract][Full Text] [Related]
7. Hispanic Ethnicity and Social Determinants of Health in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.
Bernardo RJ; Lu D; Ramirez RL; Hedlin H; Kawut SM; Bull T; De Marco T; Ford HJ; Grinnan D; Klinger JR; McConnell JW; Berman-Rosenzweig E; Shlobin OA; Zamanian RT; de Jesus Perez VA
Ann Am Thorac Soc; 2022 Sep; 19(9):1459-1468. PubMed ID: 35239467
[No Abstract] [Full Text] [Related]
8. Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry.
Chung L; Farber HW; Benza R; Miller DP; Parsons L; Hassoun PM; McGoon M; Nicolls MR; Zamanian RT
Chest; 2014 Dec; 146(6):1494-1504. PubMed ID: 24992469
[TBL] [Abstract][Full Text] [Related]
9. United States Pulmonary Hypertension Scientific Registry: Baseline Characteristics.
Badlam JB; Badesch DB; Austin ED; Benza RL; Chung WK; Farber HW; Feldkircher K; Frost AE; Poms AD; Lutz KA; Pauciulo MW; Yu C; Nichols WC; Elliott CG;
Chest; 2021 Jan; 159(1):311-327. PubMed ID: 32858008
[TBL] [Abstract][Full Text] [Related]
10. Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registry.
Hill KD; Lim DS; Everett AD; Ivy DD; Moore JD
Catheter Cardiovasc Interv; 2010 Nov; 76(6):865-73. PubMed ID: 20549685
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of Patients With Pulmonary Arterial Hypertension in a Pulmonary Hypertension Association-Accredited Comprehensive Care Center: A Contrast in Features When Compared With US National Registry Data.
Ingram D; Alamri AK; Penn BA; Mayeux JD; Ma CL; Clapham KR; Abraham AE; Klanderud D; Sadeh B; Beck EM; Hatton ND; Ryan JJ
Cureus; 2022 Nov; 14(11):e31764. PubMed ID: 36569732
[TBL] [Abstract][Full Text] [Related]
12. Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank).
Charoenpong P; Dhillon N; Murnane K; Goeders N; Hall N; Keller C; Bhuiyan MAN; Walter R
BMJ Open Respir Res; 2023 Dec; 10(1):. PubMed ID: 38061804
[TBL] [Abstract][Full Text] [Related]
13. Investigating the "sex paradox" in pulmonary arterial hypertension: Results from the Pulmonary Hypertension Association Registry (PHAR).
DesJardin JT; Kime N; Kolaitis NA; Kronmal RA; Lammi MR; Mathai SC; Ventetuolo CE; De Marco T;
J Heart Lung Transplant; 2024 Jun; 43(6):901-910. PubMed ID: 38360160
[TBL] [Abstract][Full Text] [Related]
14. The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH.
Clements PJ; Tan M; McLaughlin VV; Oudiz RJ; Tapson VF; Channick RN; Rubin LJ; Langer A;
Ann Rheum Dis; 2012 Feb; 71(2):249-52. PubMed ID: 21998119
[TBL] [Abstract][Full Text] [Related]
15. Regional Variation in Pulmonary Arterial Hypertension in the United States: The Pulmonary Hypertension Association Registry.
Fling C; De Marco T; Kime NA; Lammi MR; Oppegard LJ; Ryan JJ; Ventetuolo CE; White RJ; Zamanian RT; Leary PJ
Ann Am Thorac Soc; 2023 Dec; 20(12):1718-1725. PubMed ID: 37683277
[No Abstract] [Full Text] [Related]
16. Treatment of pulmonary arterial hypertension in connective tissue disease.
Grünig E
Drugs; 2012 May; 72(8):1039-56. PubMed ID: 22621693
[TBL] [Abstract][Full Text] [Related]
17. Age-related differences in hemodynamics and functional status in pulmonary arterial hypertension: Baseline results from the Pulmonary Hypertension Association Registry.
DesJardin JT; Kolaitis NA; Kime N; Kronmal RA; Benza RL; Elwing JM; Lammi MR; McConnell JW; Presberg KW; Sager JS; Shlobin OA; De Marco T;
J Heart Lung Transplant; 2020 Sep; 39(9):945-953. PubMed ID: 32507341
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry.
Chazova IE; Arkhipova OA; Martynyuk TV
Ter Arkh; 2019 Mar; 91(1):24-31. PubMed ID: 31090367
[TBL] [Abstract][Full Text] [Related]
19. Characteristics, Long-term Survival, and Risk Assessment of Pediatric Pulmonary Arterial Hypertension in China: Insights From a National Multicenter Prospective Registry.
Qian Y; Quan R; Chen X; Gu Q; Xiong C; Han H; Zhang G; Chen Y; Yu Z; Tian H; Liu Y; Zhu X; Li S; Zhang C; He J
Chest; 2023 Jun; 163(6):1531-1542. PubMed ID: 36470418
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
